Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $1.27 | $1.27 | $1.27 |
Q2 2024 | 2 | $1.74 | $1.74 | $1.74 |
Q3 2024 | 2 | $1.48 | $1.52 | $1.50 |
Q4 2024 | 6 | $1.68 | $1.74 | $1.72 |
Q1 2025 | 4 | $1.67 | $1.71 | $1.68 |
Q2 2025 | 2 | $1.79 | $1.85 | $1.82 |
Q3 2025 | 2 | $1.94 | $2.00 | $1.97 |
Q4 2025 | 2 | $2.05 | $2.12 | $2.08 |
Q1 2026 | 1 | $2.04 | $2.11 | $2.07 |
Q2 2026 | 1 | $2.20 | $2.28 | $2.23 |
Q3 2026 | 1 | $2.21 | $2.28 | $2.24 |
Q4 2026 | 1 | $2.28 | $2.36 | $2.31 |
West Pharmaceutical Services, Inc. last posted its earnings results on Thursday, October 24th, 2024. The company reported $1.85 earnings per share for the quarter, topping analysts' consensus estimates of $1.5 by $0.35. The company had revenue of 746.90 M for the quarter and had revenue of 2.95 B for the year. West Pharmaceutical Services, Inc. has generated $8 earnings per share over the last year ($7.88 diluted earnings per share) and currently has a price-to-earnings ratio of 48.29. West Pharmaceutical Services, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/24/2024 | Q3 2024 | $1.50 | $1.87 | 0.37 | $709.62 M | $746.90 M |
07/25/2024 | Q2 2024 | $1.74 | $1.52 | -0.22 | $729.36 M | $702.00 M |
04/25/2024 | Q1 2024 | $1.26 | $1.57 | 0.31 | $695.40 M | |
02/20/2024 | Q4 2023 | $1.85 | $732.00 M | |||
10/26/2023 | Q3 2023 | $1.86 | $2.17 | 0.31 | $750.31 M | $747.40 M |
07/27/2023 | Q2 2023 | $1.93 | $2.09 | 0.16 | $755.71 M | $753.80 M |
04/27/2023 | Q1 2023 | $1.67 | $1.88 | 0.21 | $716.60 M | |
02/21/2023 | Q4 2022 | $1.38 | $708.70 M | |||
10/27/2022 | Q3 2022 | $2.12 | $1.62 | -0.5 | $727.42 M | $686.90 M |
07/28/2022 | Q2 2022 | $2.21 | $2.53 | 0.32 | $754.25 M | $771.30 M |
04/28/2022 | Q1 2022 | $2.12 | $2.34 | 0.22 | $720.00 M | |
02/22/2022 | Q4 2021 | $1.98 | $730.80 M | |||
10/28/2021 | Q3 2021 | $1.80 | $2.37 | 0.57 | $687.09 M | $706.50 M |
07/30/2021 | Q2 2021 | $2.53 | $669.38 M | $723.60 M | ||
04/30/2021 | Q1 2021 | $2.04 | $670.70 M | |||
02/23/2021 | Q4 2020 | $1.33 | $580.20 M | |||
10/23/2020 | Q3 2020 | $1.11 | $502.72 M | $548.00 M | ||
07/24/2020 | Q2 2020 | $1.24 | $496.09 M | $527.20 M | ||
04/24/2020 | Q1 2020 | $1.01 | $491.50 M | |||
02/21/2020 | Q4 2019 | $0.86 | $470.60 M |
West Pharmaceutical Services, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
In the previous quarter, West Pharmaceutical Services, Inc. (:WST) reported $1.85 earnings per share (EPS) to beat the analysts' consensus estimate of $1.5 by $0.35.
The conference call for West Pharmaceutical Services, Inc.'s latest earnings report can be listened to online.
The conference call transcript for West Pharmaceutical Services, Inc.'s latest earnings report can be read online.
West Pharmaceutical Services, Inc. (:WST) has a recorded annual revenue of $2.95 B.
West Pharmaceutical Services, Inc. (:WST) has a recorded net income of $2.95 B. West Pharmaceutical Services, Inc. has generated $7.99 earnings per share over the last four quarters.
West Pharmaceutical Services, Inc. (:WST) has a price-to-earnings ratio of 48.29 and price/earnings-to-growth ratio is -11.44.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED